What is the address of DOCTEUR PH. MARCELLE, CARDIOLOGIE?

The registered office of DOCTEUR PH. MARCELLE, CARDIOLOGIE is located at Rue de Freloux 16, 4347 Fexhe-le-Haut-Clocher.

Is DOCTEUR PH. MARCELLE, CARDIOLOGIE still active?

Yes. According to the CBE (17 September 2026) DOCTEUR PH. MARCELLE, CARDIOLOGIE is active, legal situation “Normale toestand”, started on 23 January 2006.

Is DOCTEUR PH. MARCELLE, CARDIOLOGIE registered on Peppol?

No, DOCTEUR PH. MARCELLE, CARDIOLOGIE is currently not registered on the Peppol network.

What is the enterprise number of DOCTEUR PH. MARCELLE, CARDIOLOGIE?

The enterprise number of DOCTEUR PH. MARCELLE, CARDIOLOGIE is BE0878814060.

When was DOCTEUR PH. MARCELLE, CARDIOLOGIE founded?

DOCTEUR PH. MARCELLE, CARDIOLOGIE was founded on 23 January 2006.

Who are the directors of DOCTEUR PH. MARCELLE, CARDIOLOGIE?

According to the 2025 annual accounts, the directors of DOCTEUR PH. MARCELLE, CARDIOLOGIE are: Philippe MARCELLE.

Is DOCTEUR PH. MARCELLE, CARDIOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 January 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOCTEUR PH. MARCELLE, CARDIOLOGIE make in 2025?

DOCTEUR PH. MARCELLE, CARDIOLOGIE posted a profit after taxes of € 199,420 in financial year 2025.

What is the revenue of DOCTEUR PH. MARCELLE, CARDIOLOGIE?

As a small company, DOCTEUR PH. MARCELLE, CARDIOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 282,445.

DOCTEUR PH. MARCELLE, CARDIOLOGIE (Private Limited)

Dossier DOCTEUR PH. MARCELLE, CARDIOLOGIE, printed on 17 September 2026 from databakkes.be/en/0878814060/docteur-ph-marcelle-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DOCTEUR PH. MARCELLE, CARDIOLOGIE from Fexhe-le-Haut-Clocher, company number BE0878814060, closed financial year 2025 with a result of € 199,420 after tax. For that financial year DOCTEUR PH. MARCELLE, CARDIOLOGIE recorded a gross margin of € 282,445 and equity of € 251,810. Compared with financial year 2024, the result moved from € 200,293 to € 199,420. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 251,810

▼ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 199,420

Profit after tax over the fiscal year.

Cash in the bank

€ 136,781

▼ 43% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 248,493 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 43,800

▼ 20% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,102

▼ 27% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 62,280

▼ 25% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 56,201 Gross margin 2022: € 56,201 First fiscal year in the series	€ 276,687 Gross margin 2023: € 276,687 ▲ € 220,487 vs 2022 (€ 56,201) Favourable step	€ 288,578 Gross margin 2024: € 288,578 ▲ 4% vs 2023 (€ 276,687) Favourable step	€ 282,445 Gross margin 2025: € 282,445 ▼ 2% vs 2024 (€ 288,578) Unfavourable step	▼ 2%
Profit after taxes	€ 49,074 Profit after taxes 2022: € 49,074 First fiscal year in the series	€ 185,364 Profit after taxes 2023: € 185,364 ▲ 278% vs 2022 (€ 49,074) Favourable step	€ 200,293 Profit after taxes 2024: € 200,293 ▲ 8% vs 2023 (€ 185,364) Favourable step	€ 199,420 Profit after taxes 2025: € 199,420 Unchanged (€ 200,293) Unfavourable step
Equity	€ 49,408 Equity 2022: € 49,408 First fiscal year in the series	€ 234,772 Equity 2023: € 234,772 ▲ € 185,364 vs 2022 (€ 49,408) Favourable step	€ 300,883 Equity 2024: € 300,883 ▲ 28% vs 2023 (€ 234,772) Favourable step	€ 251,810 Equity 2025: € 251,810 ▼ 16% vs 2024 (€ 300,883) Unfavourable step	▼ 16%
Total debts	€ 75,586 Total debts 2022: € 75,586 First fiscal year in the series	€ 103,492 Total debts 2023: € 103,492 ▲ 37% vs 2022 (€ 75,586) Unfavourable step	€ 181,632 Total debts 2024: € 181,632 ▲ 76% vs 2023 (€ 103,492) Unfavourable step	€ 250,596 Total debts 2025: € 250,596 ▲ 38% vs 2024 (€ 181,632) Unfavourable step	▲ 38%
Cash	€ 61,343 Cash 2022: € 61,343 First fiscal year in the series	€ 242,889 Cash 2023: € 242,889 ▲ 296% vs 2022 (€ 61,343) Favourable step	€ 240,067 Cash 2024: € 240,067 ▼ 1% vs 2023 (€ 242,889) Unfavourable step	€ 136,781 Cash 2025: € 136,781 ▼ 43% vs 2024 (€ 240,067) Unfavourable step	▼ 43%
Retained profit	€ -16,992 Retained profit 2022: € -16,992 First fiscal year in the series	€ 168,372 Retained profit 2023: € 168,372 ▲ € 185,364 vs 2022 (€ -16,992) Favourable step	€ 234,483 Retained profit 2024: € 234,483 ▲ 39% vs 2023 (€ 168,372) Favourable step	€ 185,410 Retained profit 2025: € 185,410 ▼ 21% vs 2024 (€ 234,483) Unfavourable step	▼ 21%
Dividend	€ 32,084 Dividend 2022: € 32,084 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 32,084) Unchanged	€ 134,182 Dividend 2024: € 134,182 Unchanged (€ 0) Unchanged	€ 248,493 Dividend 2025: € 248,493 ▲ 85% vs 2024 (€ 134,182) Unchanged	▲ 85%
Balance sheet total	€ 124,994 Balance sheet total 2022: € 124,994 First fiscal year in the series	€ 338,263 Balance sheet total 2023: € 338,263 ▲ 171% vs 2022 (€ 124,994) Unchanged	€ 482,515 Balance sheet total 2024: € 482,515 ▲ 43% vs 2023 (€ 338,263) Unchanged	€ 502,405 Balance sheet total 2025: € 502,405 ▲ 4% vs 2024 (€ 482,515) Unchanged	▲ 4%

Key figures of DOCTEUR PH. MARCELLE, CARDIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOCTEUR PH. MARCELLE, CARDIOLOGIE?

What happened at DOCTEUR PH. MARCELLE, CARDIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 199,420. filed late Source: NBB ↗
Jan 23, 2006 Start of the company according to the CBE. KBO

In short

From € 49,074 profit in 2022 to € 199,420 profit in 2025.

Paid € 241,251 in corporate taxes since 2022.

Best year ever: 2024, with € 200,293 profit.

Paid out € 414,759 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOCTEUR PH. MARCELLE, CARDIOLOGIE? We notify you, reason included.

Follow DOCTEUR PH. MARCELLE, CARDIOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Philippe MARCELLE

DOCTEUR PH. MARCELLE, CARDIOLOGIE

Behind DOCTEUR PH. MARCELLE, CARDIOLOGIE is Philippe MARCELLE.

See the full network in the app

Directors

According to the 2025 annual accounts

Philippe MARCELLE

Managing director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Freloux 16

4347 Fexhe-le-Haut-Clocher

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0878.814.060
VAT number: BE 0878.814.060
Registered office: Rue de Freloux 16, 4347 Fexhe-le-Haut-Clocher
Names & denominations: DOCTEUR PH. MARCELLE, CARDIOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 January 2006
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗